ALERT: MERGER - CLEARANCE - VERTICAL EFFECTS

Clearance: The French Competition Authority clears a merger in the sector of medical biology analysis (Bio Alfras/Eurofins)

Autorité de la concurrence, 7 octobre 2015, décision n° 15-DCC-135 (Bio Alfras/Eurofins) La décision n° 15-DCC-135 du 7 octobre 2015 concerne la prise de contrôle exclusif de la société Bio Alfras (groupe Biomnis) par la société Eurofins. Eurofins détient des laboratoires d’analyses médicales dont l’activité consiste en

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • L’actu-concurrence (Paris)

Quotation

Alain Ronzano, Clearance: The French Competition Authority clears a merger in the sector of medical biology analysis (Bio Alfras/Eurofins), 7 October 2015, Concurrences Review N° 1-2016, Art. N° 78035, www.concurrences.com

Visites 79

All reviews